Durvalumab as Consolidation Therapy in Post-Multimodal Interventional Treatment for Patients with Advanced Solid Tumors: A Preliminary Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/7794840
Abstract: With 2.1 million unique cases of lung tumors and 1.8 million mortalities in China, advanced solid tumors continue to be the primary source of cancer mortality rates. Nearly two-thirds of lung cancer individuals display advanced-stage… read more here.
Keywords: advanced solid; therapy post; consolidation therapy; solid tumors ... See more keywords
CD19-CAR-T cells are an effective therapy of post-transplant relapse in B- ALL patients: Real-World Data from Germany.
Sign Up to like & getrecommendations! Published in 2023 at "Blood advances"
DOI: 10.1182/bloodadvances.2022008981
Abstract: Key Points • Most patients with refractory B-ALL could achieve remission with a single infusion of CAR T cells.• Survival probability is excellent for patients who relapsed >6 months posttransplant and poor for patients who… read more here.
Keywords: effective therapy; cd19 car; car; cells effective ... See more keywords